| abstract |
An object of the present invention is to provide a T-cell receptor useful for the prevention or treatment of cancer, particularly hematopoietic malignancies. A T-cell receptor comprising a β-chain comprising a β-chain CDR3 comprising an amino acid sequence shown by a specific sequence and another α-chain comprising an α-chain CDR3 comprising an amino acid sequence shown by another specific specific sequence. It is a T-cell receptor that recognizes HLA-DPB1*02:01, HLA-DPB1*09:01, HLA-DPB1*03:01, or HLA-DPB1*04:02. [Selection figure] None |